Published in Joint Bone Spine on December 21, 2009
Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol (2012) 1.41
Osteoarthritis year 2011 in review: biology. Osteoarthritis Cartilage (2011) 0.95
Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomedicine (Lond) (2010) 0.94
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization. Angiogenesis (2011) 0.94
Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family. J Cell Biochem (2012) 0.94
Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. J Clin Invest (2014) 0.91
Role of placenta growth factor in cancer and inflammation. Exp Mol Med (2012) 0.86
Calreticulin promotes angiogenesis via activating nitric oxide signalling pathway in rheumatoid arthritis. Clin Exp Immunol (2014) 0.85
STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration. Curr Mol Med (2016) 0.83
Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Ther Adv Musculoskelet Dis (2014) 0.82
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide. Ann Rheum Dis (2012) 0.81
Role of plasma kallikrein-kinin system activation in synovial recruitment of endothelial progenitor cells in experimental arthritis. Arthritis Rheum (2012) 0.80
The rs3768777-G allele of ITGAV gene is associated with rheumatoid arthritis. Rheumatol Int (2013) 0.77
Temporal cytokine expression and the target organ attributes unravel novel aspects of autoimmune arthritis. Indian J Med Res (2013) 0.76
Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis. Sci Rep (2017) 0.75
NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis. Arthritis Res Ther (2013) 0.75
Paclitaxel suppresses collagen-induced arthritis: a reevaluation. Am J Transl Res (2016) 0.75
TLRs, future potential therapeutic targets for RA. Autoimmun Rev (2016) 0.75
The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation. Biomolecules (2015) 0.75
Effects of salbutamol on the inflammatory parameters and angiogenesis in the rat air pouch model of inflammation. Res Pharm Sci (2017) 0.75
Angiogenic factors. Science (1987) 15.22
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A (1994) 6.48
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature (2008) 5.85
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (1990) 5.15
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem (1995) 4.77
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood (2000) 4.34
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell (2003) 3.66
Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol (1983) 3.60
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum (2003) 3.29
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (1995) 3.07
YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst (2003) 2.91
Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol (2004) 2.81
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol (1994) 2.66
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov (2006) 2.30
Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol (2007) 2.20
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol (2000) 2.17
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum (2005) 1.67
Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res (2003) 1.57
Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem (2007) 1.52
Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther (2008) 1.52
Type IV collagen-derived angiogenesis inhibitors. Microvasc Res (2007) 1.51
Mechanisms of Disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol (2007) 1.48
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett (2006) 1.41
Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol (2003) 1.34
Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol (2007) 1.30
Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol (2005) 1.29
Differential expression of the FAK family kinases in rheumatoid arthritis and osteoarthritis synovial tissues. Arthritis Res Ther (2007) 1.25
Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo. J Immunol (2006) 1.24
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther (2007) 1.23
VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opin Investig Drugs (2007) 1.23
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage (2005) 1.22
Chemokines and angiogenesis. Curr Opin Rheumatol (2001) 1.20
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther (2003) 1.20
Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol Ther (2002) 1.19
In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum (2007) 1.18
Update on cytokines in rheumatoid arthritis. Curr Opin Rheumatol (2007) 1.17
Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J Immunol (2000) 1.17
Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum (2006) 1.15
The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther (2007) 1.12
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther (2004) 1.09
AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro. J Cardiovasc Pharmacol (2007) 1.07
Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum (2006) 1.04
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford) (2004) 1.02
Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis. Arthritis Rheum (2006) 1.02
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol (2004) 1.01
Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum (2007) 1.00
Therapies directed at vascular endothelial growth factor. Expert Opin Investig Drugs (2002) 0.98
Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum (2007) 0.97
Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action. Int Immunopharmacol (2008) 0.96
Role of adhesion molecules in synovial inflammation. Curr Opin Rheumatol (2006) 0.95
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol (2006) 0.95
Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin Exp Immunol (2007) 0.93
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract Res Clin Rheumatol (2006) 0.93
Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis. Inflamm Res (2004) 0.92
The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis. Arthritis Res Ther (2002) 0.90
Design and synthetic considerations of matrix metalloproteinase inhibitors. Ann N Y Acad Sci (1999) 0.89
Upregulation of kallistatin expression in rheumatoid joints. J Rheumatol (2007) 0.89
Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Res Ther (2005) 0.86
Junctional adhesion molecules in angiogenesis. Front Biosci (2008) 0.83
Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol (2007) 2.20
Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum (2006) 1.92
Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol (2002) 1.83
Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol (2011) 1.62
Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum (2005) 1.58
Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res (2003) 1.57
Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb Haemost (2011) 1.53
Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine. Arthritis Rheumatol (2014) 1.53
Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther (2008) 1.52
Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol (2003) 1.49
Mechanisms of Disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol (2007) 1.48
Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest (2003) 1.48
Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol (2010) 1.45
Suppression of endothelial cell activity by inhibition of TNFα. Arthritis Res Ther (2012) 1.44
Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol (2008) 1.39
Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci (2007) 1.36
CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res (2008) 1.33
Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood (2005) 1.32
Genetics of rheumatoid arthritis - a comprehensive review. Clin Rev Allergy Immunol (2013) 1.31
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol (2008) 1.29
Differential expression of the FAK family kinases in rheumatoid arthritis and osteoarthritis synovial tissues. Arthritis Res Ther (2007) 1.25
Angiogenesis and its targeting in rheumatoid arthritis. Vascul Pharmacol (2009) 1.24
Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (2006) 1.22
IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J Immunol (2003) 1.20
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther (2006) 1.19
Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res (2002) 1.19
In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum (2007) 1.18
CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res (2008) 1.18
Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis. J Immunol (2005) 1.18
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis. Arthritis Rheum (2012) 1.18
The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum (2007) 1.16
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc Natl Acad Sci U S A (2008) 1.15
Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J Biol Chem (2002) 1.14
CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum (2006) 1.13
Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Arthritis Rheum (2003) 1.09
[Successful treatment of life-threatening, treatment resistant Clostridium difficile infection associated pseudomembranous colitis with faecal transplantation]. Orv Hetil (2012) 1.08
[Detailed methodological recommendations for the treatment of Clostridium difficile-associated diarrhea with faecal transplantation]. Orv Hetil (2013) 1.07
Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression. Hepatology (2006) 1.07
Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed) (2010) 1.06
Vascular endothelium and immune responses: implications for inflammation and angiogenesis. Rheum Dis Clin North Am (2004) 1.04
Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res (2011) 1.04
Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis. Arthritis Rheum (2006) 1.02
Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. J Cell Mol Med (2002) 1.01
Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol (2010) 1.00
Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum (2007) 1.00
Reference genes for quantitative real time PCR in UVB irradiated keratinocytes. J Photochem Photobiol B (2008) 0.99
A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. J Biol Chem (2003) 0.98
Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum (2008) 0.98
Chemokines in rheumatic diseases. Curr Drug Targets (2006) 0.97
125I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano (2011) 0.97
Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice. Am J Physiol Gastrointest Liver Physiol (2008) 0.96
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus. Ann N Y Acad Sci (2007) 0.96
Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology (Oxford) (2009) 0.95
Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum (2010) 0.95
Angiogenesis in rheumatoid arthritis. Autoimmunity (2009) 0.95
Therapeutic inhibition of leukocyte recruitment in inflammatory diseases. Curr Opin Pharmacol (2004) 0.95
Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood (2003) 0.94
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther (2011) 0.94
Chemokine receptor expression in rat adjuvant-induced arthritis. Arthritis Rheum (2005) 0.94
Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum Gene Ther (2002) 0.94
Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-kappaB activation and oxidative stress. Carcinogenesis (2006) 0.94
Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis. Arthritis Rheum (2013) 0.94
Mechanism by which H-2g, a glucose analog of blood group H antigen, mediates angiogenesis. Blood (2004) 0.94
Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus. Med Sci Monit (2012) 0.94
Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis. Arthritis Res Ther (2010) 0.93
Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases. Ann Rheum Dis (2010) 0.92
Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer. Pathol Oncol Res (2012) 0.92
Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha-induced apoptosis. Arthritis Rheum (2009) 0.91
The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp Mol Pathol (2003) 0.91
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol (2008) 0.90
Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008. Arch Med Sci (2010) 0.90
Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human complement. J Immunol (2006) 0.90
Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages. Thromb Haemost (2010) 0.88
Effect of hyperlipidemia on QT dispersion in patients without ischemic heart disease. Can J Cardiol (2005) 0.88
Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts. Curr Rheumatol Rep (2012) 0.88
Role of aggrecanase 1 in Lyme arthritis. Arthritis Rheum (2006) 0.88
How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines? Arch Med Sci (2012) 0.87
H-2g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum (2008) 0.87
Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A. Arthritis Rheum (2010) 0.87
HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats. Anticancer Res (2003) 0.87
The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford) (2009) 0.86
Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry (2010) 0.86
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage. Eur J Clin Pharmacol (2004) 0.86
Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation? Ann N Y Acad Sci (2007) 0.86
Endothelial cells in inflammation and angiogenesis. Curr Drug Targets Inflamm Allergy (2005) 0.86
Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair. Am J Respir Crit Care Med (2010) 0.86
Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts. Arthritis Rheum (2011) 0.85
The prevalence of adolescent hypertension in Hungary - the Debrecen hypertension study. Blood Press (2010) 0.85
Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. J Hypertens (2010) 0.84
Identification of a novel deletion in the ABCC6 gene leading to Pseudoxanthoma elasticum. J Dermatol Sci (2005) 0.84
Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity. J Am Coll Nutr (2011) 0.84
Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis. Arthritis Rheum (2012) 0.84
Chemokines and angiogenesis in rheumatoid arthritis. Front Biosci (Elite Ed) (2009) 0.84
Gene therapy for rheumatoid arthritis: recent advances. Curr Gene Ther (2008) 0.83
The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome. J Membr Biol (2007) 0.83